What is Insmed's federal?

Insmed (INSM) reported federal of $0.00 in Q4 2025.

What is the long-term trend for Insmed's federal?

Over 4 years (2021 to 2025), Insmed's federal has grown at a -100.0% compound annual growth rate (CAGR), from -$2.84M to $0.00.

Federal tax expense or benefit that will be realized in future periods.

Discontinued — last reported Q4 '22

Over 4 years (FY 2021 to FY 2025), Federal shows an upward trend with a -100.0% CAGR.

StatementIncome Statement

SectionOther

CategoryProfitability

SignalContext dependent

VolatilityModerate

First reportedQ1 2015

Last reportedQ4 2022

Indicates timing differences between accounting profit and taxable income.

The change in deferred federal tax liabilities or assets resulting from temporary differences between the financial repo...

Standard tax disclosure for all corporations.

Metric ID: other_deferred_federal_income_tax_expense_benefit

5 years

	FY'21	FY'22	FY'23	FY'24	FY'25
Value	-$2.84M	$13.00K	-$13.00K	$0.00	$0.00
YoY Change	—	+100.5%	-200.0%	+100.0%	—

Range-$2.84M – $13.00K

CAGR-100.0%

Avg YoY Growth+0.2%

Median YoY Growth+100.0%

What is Insmed's federal?: Insmed (INSM) reported federal of $0.00 in Q4 2025.
What is the long-term trend for Insmed's federal?: Over 4 years (2021 to 2025), Insmed's federal has grown at a -100.0% compound annual growth rate (CAGR), from -$2.84M to $0.00.
What does federal mean?: Federal tax expense or benefit that will be realized in future periods.